In October 2025, the FDA issued a safety communication warning that radiofrequency (RF) microneedling has been linked to reports of serious complications, including burns, scarring, fat loss, disfigurement, and nerve damage. If you're considering this treatment, the FDA's core message is straightforward: RF microneedling is a medical procedure, not a spa-level cosmetic treatment, and it should only be performed by a licensed provider who is specifically trained on the exact device being used. This article breaks down what the FDA has verified, what it hasn't, and what questions its safety communication suggests you ask before you book anything.
By NovaMedSpa.com Beauty & Wellness Team. This page reflects publicly available FDA safety information as of the date below and does not describe any provider, product, or service.
If You've Already Had the Procedure and Something Feels Wrong
The FDA's safety communication asks patients to contact a licensed provider promptly if they notice unexpected pain, blistering, numbness, unusual firmness, skin discoloration, or a wound that isn't healing after RF microneedling. If you're experiencing a medical emergency, such as severe pain, spreading redness with fever, or signs of a serious allergic reaction, contact local emergency services right away rather than waiting for a callback. This article is general education, not a diagnosis or a substitute for evaluation by a licensed medical professional.
What Radiofrequency Microneedling Actually Is
Traditional microneedling uses fine needles to create tiny, controlled injuries in the skin, which the FDA classifies as a medical device function once the needles penetrate the epidermis and dermis. RF microneedling adds a second layer: the needles also deliver radiofrequency energy beneath the skin's surface, intended to heat deeper tissue for effects marketed as “tightening” or “resurfacing.”
According to the FDA, microneedling devices are regulated as medical devices and cleared through the agency's 510(k) or De Novo pathways for a limited set of authorized uses, in patients 22 and older, such as improving the appearance of facial acne scars, facial wrinkles, and abdominal scars. RF microneedling devices fall under this same device-classification framework, but the added radiofrequency component is what the FDA's newer safety communication specifically addresses.
The Evidence Ladder: What's Verified, By Whom, and How Strongly
Not all claims about a medical device carry the same weight. Here's how the sourcing breaks down for RF microneedling, from strongest to weakest:
- Verified — FDA safety communication (October 15, 2025): The FDA has confirmed reports of serious adverse events tied to RF microneedling, including burns, scarring, fat loss, disfigurement, and nerve damage, with some cases requiring surgical repair or other medical intervention. This is the highest-strength claim on this page because it comes directly from the federal regulator monitoring the device category.
- Verified — FDA device classification page: RF and standard microneedling devices that penetrate the epidermis and dermis are regulated as medical devices, cleared through 510(k) or De Novo pathways, with common side effects listed as dryness, redness, itching, peeling, bruising, and crusting, and less common risks including pigment changes, herpes reactivation, and infection.
- Verified — reporting mechanism exists: The FDA operates a public MedWatch voluntary reporting system where patients and providers can report suspected device-related complications directly to the agency.
- Not addressed by these sources: How common serious complications are as a percentage of total RF microneedling procedures performed, which specific device models or settings carry higher risk, and how outcomes compare across provider experience levels. The FDA's communication describes the existence and nature of reports, not an incidence rate.
Known vs. Unknown
Separating what regulators have confirmed from what remains unclear helps set realistic expectations before any consultation.
- Known: RF microneedling devices are FDA-regulated medical devices, not over-the-counter beauty tools.
- Known: The FDA has received reports of serious complications specifically tied to RF microneedling, prompting the October 2025 safety communication.
- Known: The FDA recommends treatment only from licensed providers trained on the specific device model being used.
- Unknown from public FDA sources: The exact number or rate of serious complications relative to total procedures performed nationally.
- Unknown from public FDA sources: Whether risk varies meaningfully by energy setting, needle depth, treatment area, or device brand, since the communication addresses the category rather than ranking individual products.
- Not something this article can tell you: Whether RF microneedling is appropriate for your skin, medical history, or goals. That determination requires an individualized evaluation by a licensed provider.
A Practical Checklist Before Any Consultation
The FDA's safety communication is written for patients as much as providers. Translated into a checklist, these are the questions its guidance points toward asking before you agree to RF microneedling:
- Ask whether the provider is licensed to perform medical aesthetic procedures in your state.
- Ask what specific training the provider has completed on the exact RF microneedling device they plan to use, not just microneedling in general.
- Ask them to walk through the realistic range of possible side effects, including the serious ones named in the FDA communication, not only the common, mild ones.
- Ask what happens if something goes wrong: who you'd contact, how quickly, and whether they handle complications in-house or refer out.
- Ask about your own contraindications, such as bleeding disorders, active skin infection, uncontrolled diabetes, certain medications, or pregnancy, since these are flagged as relevant risk factors for microneedling generally.
- Confirm that a new, single-use needle cartridge will be used for your treatment, since reuse between patients carries infection-transmission risk.
- If you experience an unexpected reaction after treatment, know that you can report it yourself through the FDA's MedWatch voluntary reporting form, in addition to contacting your provider.
What This Article Is Not
This page does not recommend for or against RF microneedling, any provider, any device brand, or any specific treatment plan. It is not a substitute for a consultation with a licensed medical professional, and it does not diagnose or treat any condition. Individual risk, suitability, and outcomes vary and can only be assessed by a qualified provider who reviews your specific health history in person.
Sources and Methodology
This article draws directly from two current FDA pages: the FDA's October 15, 2025 safety communication on RF microneedling, and the FDA's microneedling devices regulatory overview, which together cover device classification, authorized uses, common and serious risks, and reporting mechanisms. For general background on the FDA's oversight of aesthetic devices, see the agency's medical device safety communications index. For more on how this publication sources and verifies information like the facts above, see our Editorial Policy. This article is filed under our Skin Health and Aging coverage.
Last updated September 15, 2026. Nova Med Spa is an independent educational publication and is not a medical spa, clinic, or healthcare provider. This article is general information only and is not medical advice, diagnosis, or treatment. Always consult a licensed medical professional about your individual situation.